Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
acquisition, Additionally, alopecia, bore, cease, copy, crypt, default, description, diarrhea, doubt, encouraging, foregoing, foundational, hair, identification, immunomodulation, intestinal, lurbinectedin, objective, premium, presence, profile, recoverability, release, sacituzumab, scheduled, Topic, Treasury
Removed:
ATM, bear, decline, dual, harmed, lose, revert, unaware
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view